Odomzo Approved for Advanced Skin Cancer

The FDA has approved Odomzo (sonidegib) capsules for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

Cancer Patients Need Fertility Preservation Awareness

Many young cancer patients have limited awareness about options to preserve their fertility.

ED Drugs and Melanoma Risk

Patients taking medications for erectile dysfunction (ED) may have an increased risk of melanoma but these drugs are not a cause of melanoma.

Chili Pepper Toxin, Gallbladder Cancer Risk

Gallbladder cancer seems to be associated with aflatoxin, according to a new study.

No Link Between PTSD, Cancer

While the potential relationship between stress and cancer has been a topic of discussion and research for over 70 years, no association between post-traumatic stress disorder (PTSD) and cancer was found in the largest study to date.

Cyramza Gains Colon Cancer Indication

The FDA has expanded the indication of Cyramza (ramucirumab; Eli Lilly) for use in combination with irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- and fluoropyrimidine-containing regimen.

Fish Oil May Hinder Chemotherapy Effectiveness

Fish oil supplements, and even certain fish, may hinder the effectiveness of chemotherapy.

Stroke Risk Up After Cancer Diagnosis

Cancer increases the risk of stroke independently of other stroke risk factors, such as hypertension and diabetes.

News

Urine Test May Help ID Pancreatic Cancer Earlier

Urine Test May Help ID Pancreatic Cancer Earlier

Elevated levels of three proteins detected in urine of early-stage pancreatic cancer patients

Factors ID'd for MAPK Treatment Outcome in Melanoma

Factors ID'd for MAPK Treatment Outcome in Melanoma

For patients with metastatic melanoma treated with mitogen-activated protein kinase (MAPK) inhibitors, gender, serum lactate dehydrogenase (LDH), BRAF genotype, and primary melanoma ulceration status are independent factors associated with treatment outcomes.

Adjunctive Telotristat Demonstrates Efficacy in Carcinoid Syndrome

Lexicon announced top-line results from the Phase 3 study, TELESTAR, which evaluated oral telotristat etiprate in cancer patients with carcinoid syndrome that is not adequately controlled by the current standard of care.

Performance Indicators for Mammography Correlate Well With Clinical Audit

Performance Indicators for Mammography Correlate Well With Clinical Audit

Some performance indicators for mammography test sets are associated with aspects of clinical audit parameters.

Tyrosine Kinase Inhibitors Appear Safe in CML With CKD

Tyrosine Kinase Inhibitors Appear Safe in CML With CKD

Tyrosine kinase inhibitors (TKIs) appear to be safe in patients with chronic-phase (CP) chronic myeloid leukemia (CML) and chronic kidney disease (CKD).

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

Comprehensive Review of Radiation OncologyExternal web site

Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...

CME 24.00 Credits

Chronic Pain ManagementExternal web site

This activity is designed to change health provider attitudes on chronic pain and willingness to ...

CME|CE 2.00 Credits

Cannabinoid Offers Modest Relief From Pain, SpasticityExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters